4.36
5.42%
-0.25
プレマーケット:
4.36
Acelyrin Inc (SLRN) 最新ニュース
Acelyrin Inc Inc. (SLRN) Price Performance: The Role of Supply and Demand - The InvestChronicle
The InvestChronicle
Insiders In Acelyrin Left Out From 11% Price Rise After Disposing Stock - Simply Wall St
Simply Wall St
Superstring Capital Management LP Makes New Investment in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat
MarketBeat
325,549 Shares in Acelyrin, Inc. (NASDAQ:SLRN) Bought by Sectoral Asset Management Inc. - MarketBeat
MarketBeat
Selling Buzz: Acelyrin Inc [SLRN] Chief Executive Officer Lin Shao-Lee sells 9961 shares of the company – Knox Daily - Knox Daily
Knox Daily
Acelyrin Inc (SLRN) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
The InvestChronicle
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones - br.ADVFN.com
br.ADVFN.com
Stocks of Acelyrin Inc (SLRN) are poised to climb above their peers – Sete News - SETE News
SETE News
Capstone Investment Advisors LLC Makes New $204000 Investment in Acelyrin, Inc. (NASDAQ:SLRN) - Defense World
Defense World
Acelyrin, Inc. (NASDAQ:SLRN) Stock Position Lowered by Swiss National Bank - Defense World
Defense World
Financial Snapshot: Analyzing Acelyrin Inc (SLRN)'s Key Ratio Metrics – DWinneX - The Dwinnex
The Dwinnex
Acelyrin, Inc. (NASDAQ:SLRN) Short Interest Update - Defense World
Defense World
Acelyrin Inc [NASDAQ: SLRN] Sees Decrease in Stock Value – Knox Daily - Knox Daily
Knox Daily
Acelyrin, Inc. (NASDAQ:SLRN) Sees Significant Decline in Short Interest - MarketBeat
MarketBeat
Decheng Capital LLC Invests $10.23 Million in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat
MarketBeat
Dynamic Technology Lab Private Ltd Takes $108000 Position in Acelyrin, Inc. (NASDAQ:SLRN) - Defense World
Defense World
Dynamic Technology Lab Private Ltd Takes $108000 Position in Acelyrin, Inc. (NASDAQ:SLRN) - Defense World
Defense World
Biopharma Comp Acelyrin Seeks USD 1.5 Bln Valuation In US IPO - BW Healthcare
BW Healthcare
Jump Financial LLC Grows Stock Position in Acelyrin, Inc. (NASDAQ:SLRN) - Defense World
Defense World
Q2 2024 Earnings Estimate for Acelyrin, Inc. (NASDAQ:SLRN) Issued By HC Wainwright - Defense World
Defense World
HC Wainwright Comments on Acelyrin, Inc.'s Q2 2024 Earnings (NASDAQ:SLRN) - MarketBeat
MarketBeat
Piper Sandler bullish on Acelyrin stock, cites major catalysts on horizon - Investing.com
Investing.com
Piper Sandler bullish on Acelyrin stock, cites major catalysts on horizon By Investing.com - Investing.com
Investing.com
Acelyrin Inc [NASDAQ: SLRN] Sees Increase in Stock Value – Knox Daily - Knox Daily
Knox Daily
Acelyrin Inc (SLRN) Stock: A Year of Decreases and Increases - The InvestChronicle
The InvestChronicle
Acelyrin (NASDAQ:SLRN) Price Target Raised to $18.00 at HC Wainwright - Defense World
Defense World
Acelyrin (NASDAQ:SLRN) Price Target Raised to $18.00 at HC Wainwright - Defense World
Defense World
Acelyrin (NASDAQ:SLRN) Price Target Increased to $18.00 by Analysts at HC Wainwright - MarketBeat
MarketBeat
How does Acelyrin Inc (SLRN) change from a tortoise to a hare? – Sete News - SETE News
SETE News
Cour Pharmaceuticals tabs ex-Acelyrin chief Paul Peloso, MD as medical head - MM+M Online
MM+M Online
Was anything negative for Acelyrin Inc (SLRN) stock last session? – US Post News - US Post News
US Post News
Cour Pharmaceuticals tabs ex-Acelyrin chief Paul Peloso, MD as medical head - MM+M Online
MM+M Online
Acelyrin (NASDAQ:SLRN) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
New York State Common Retirement Fund Boosts Stock Position in Acelyrin, Inc. (NASDAQ:SLRN) - Defense World
Defense World
Acelyrin (NASDAQ:SLRN) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - ForexTV.com
ForexTV.com
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Long-Term Stockholders and ... - GlobeNewswire
GlobeNewswire
Q2 2024 EPS Estimates for Acelyrin, Inc. (NASDAQ:SLRN) Lifted by HC Wainwright - MarketBeat
MarketBeat
HC Wainwright Weighs in on Acelyrin, Inc.'s Q2 2024 Earnings (NASDAQ:SLRN) - Defense World
Defense World
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - ForexTV.com
ForexTV.com
Acelyrin (NASDAQ:SLRN) Rating Reiterated by HC Wainwright - MarketBeat
MarketBeat
You might want to take a look at Acelyrin Inc (SLRN) now – Sete News - SETE News
SETE News
Acelyrin (NASDAQ:SLRN) Rating Reiterated by HC Wainwright - MarketBeat
MarketBeat
SLRN overperforms with a 0.21 increase in share price – US Post News - US Post News
US Post News
Biopharma firm Acelyrin seeks $1.5 billion valuation in US IPO - Yahoo Movies Canada
Yahoo Movies Canada
SLRN overperforms with a 0.21 increase in share price – US Post News - US Post News
US Post News
Investigation announced for Long-Term Investors in shares of Acelyrin, Inc. (NASDAQ: SLRN) - openPR
openPR
Acelyrin provides business and milestone update - TipRanks.com - TipRanks
TipRanks
Zurcher Kantonalbank Zurich Cantonalbank Acquires 9203 Shares of Acelyrin, Inc. (NASDAQ:SLRN) - Defense World
Defense World
Acelyrin (SLRN) Scheduled to Post Earnings on Monday - Defense World
Defense World
大文字化:
|
ボリューム (24 時間):